Dr Jan Pol

 

All American Licensing To Rep World-Renowned TV Veterinarian Dr. Jan Pol

New Dr. Pol Brand Will Launch Nationally & Include

Wide Offerings of New Dog & Farm-Related Products

 

Los Angeles, CA, October 1, 2018 - All American Licensing (AAL) has announced the signing of Dr. Jan Pol, the charismatic and internationally-acclaimed veterinarian and star of the wildly successful television series The Incredible Dr. Pol, to an exclusive licensing agreement. The new deal calls for AAL to develop a comprehensive portfolio of new food products, toys and other accessories which will feature the Dr. Pol brand imprint. Dr. Pol’s initial foray into consumer products will feature a full-range of both traditional pet categories as well as farm animal solutions.

The Incredible Dr. Pol, a reality TV series set in rural Michigan, currently airs on Nat Geo WILD, making it the network’s #1 rated program, with over 100 episodes produced to date. A true television icon, Dr. Pol has recently been featured in dozens of major media outlets, including USA Today, Parade Magazine, TV Guide, Los Angeles Times, New York Daily News, Chicago Tribune, and top TV shows including HLN’s Michae LA, Fox & Friends, The Doctors, Home & Family, Adult Swim, Good Day LA, and many others.

States Dr. Pol, “I’m excited to incorporate the insights I’ve learned in my many years of veterinary experience, collaborating with AAL to develop an affordable and practical line of animal products that are unique to the marketplace.”

Michael Gottsegen, Co-Founding Partner of All American Licensing, commented, “We’re thrilled to be working with Dr. Pol and his dedicated team – wonderful people who are truly inspired to help not just dogs and cats, but all animals remain healthy and strong through proper care, vaccinations, and grooming.” 

“Our strategy is to align Dr. Pol with retailers that will embrace his philosophy and dedication to providing the best service for the care and treatment of all animals, both large and small,” adds Tim Rothwell, AAL Co-Founding Partner.

About Dr. Jan Pol:

“In this business, it is totally unpredictable what you’re going to get, day to day. Animals don’t wait to get sick, and they don’t take appointments. They get sick, and they need to be seen.  So some days, you’re gonna go in, and there’s gonna be nothing going on. And other days, you’re gonna go in, and you can’t run fast enough.”– Dr. Jan Pol

With more than 40 years of veterinary experience, Dr. Jan Pol is a pioneer in treating animals. He is also star of Nat Geo WILD’s #1 series The Incredible Dr. Pol, which follows the unflappable and unstoppable vet on his routine 14-hour workdays treating both pets and livestock. A graduate of the prestigious Utrecht University Veterinary program in The Netherlands, Dr. Pol immigrated to the United States in 1971. After ten years of practice, he moved to Weidman, Michigan, in 1981 and founded Pol Veterinary Services out of his garage with his wife, Diane. With a down-to-earth, practical approach to veterinary medicine, Dr. Pol grew his practice from a humble start to one with over 23,000 clients.

Specializing in large farm animals, Dr. Pol treats horses, pigs, cows, sheep, alpacas, goats, chickens and even an occasional reindeer.  A true friend of the farmer, he works tirelessly to ensure that the diminishing population of family farmers remains in business.  And he plays an integral role in keeping farmers’ livestock healthy and their businesses profitable.  Dr. Pol works with many 4-H groups and feels every child should grow up with a pet.  For that reason, he tries to keep pet ownership affordable.

With his thick Dutch accent, signature mustache, vintage 1981 “Back to the Future” DeLorean car, down-to-earth practical approach and fun-loving, never give up attitude, Dr. Jan Pol is nothing short of a local legend and America’s favorite veterinarian!  

About ALL AMERICAN LICENSING:

All American Licensing is a full-service licensing agency specializing in licensing, retail development and product integration. AAL has an impressive and diverse roster of clients ranging from top consumer brands to world-class resort brands, lifestyle and pet brands.

Founded in 2011 by veteran licensing executives Tim Rothwell and Michael Gottsegen, All American Licensing provides its clients with a global network of best-in-class manufacturers; turnkey brand representation from legal and financial services to retail development to personalized road maps to success.

The company is headquartered in Los Angeles, with offices in Charleston, SC and Charlotte, NC and Canada. For more information on All American Licensing, please visit https://aalmg.com/

.

Media Contact:


Dan Harary

The Asbury PR Agency

Beverly Hills, CA

310-859-1831

dan@asburypr.com

newswirelogo

  • SHANGHAI, China, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, today announced that the first patient has been dosed in a Phase 1b/2 study evaluating FGF401 in combination with PD-1 inhibitor, pembrolizumab, in patients with advanced solid tumors, such as hepatocellular carcinoma (HCC).

  • 中国上海, Aug. 07, 2020 (GLOBE NEWSWIRE) -- 云顶新耀(Everest Medicines),一家专注于创新药开发及商业化的生物制药公司,致力于满足大中华区及其它亚洲市场未被满足的医疗需求,今日宣布在FGF401联合PD-1抑制剂Pembrolizumab用于治疗晚期实体瘤(例如肝细胞癌)的1b/2期临床研究中完成首例受试者给药。

  • HOUSTON, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Houston Wire & Cable Company (NASDAQ: HWCC) (the “Company”) announced operating results for the second quarter ended June 30, 2020 and progress on its cost and debt reduction programs.

  • CAMBRIDGE, Mass., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI), a clinical stage biotechnology company focused on developing proprietary technology to harness the power of the immune system to combat cancer, today announced the pricing of its initial public offering of 5,000,000 shares of common stock at a public offering price of $15.00 per share. All of the shares are being offered by Checkmate. Checkmate’s common stock is expected to begin trading on the Nasdaq Global Market under the ticker symbol “CMPI” on August 7, 2020. The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Checkmate, are expected to be approximately $75,000,000. The offering is expected to close on August 11, 2020, subject to the satisfaction of customary closing conditions. Checkmate has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock at the initial public offering price, less the underwriting discounts and commissions.

  • AUSTIN, Texas, Aug. 06, 2020 (GLOBE NEWSWIRE) -- ESW Capital, LLC (“ESW”) – confirms that it has delivered today an application to the Ontario Securities Commission (the “OSC”) for an exemption from the “majority of the minority” requirement contained in Section 2.29.1(c) of National Instrument 62-104 (the “Exemption”) in connection with its previously announced intention to make an offer to acquire any and all subordinate voting shares (the “Shares”) in the capital of Optiva, Inc. (TSX:OPT) (“Optiva”) at the price of CAD $60 per Share (the “Offer”).

Contact Us

Retail Merchandiser Magazine

Cringleford Business Centre,
Intwood Road Cringleford,
Norwich, UK, NR6 4AU

  +44 (0) 1603 274 130

Click here for a full list of contacts.

Back To Top